With the number of new variants emerging the diagnostic performance of testing is becoming a concern. Questions are being raised on the SARS-COV-2 strains and their functioning on the antigen test. The debate is on if the resultant test is able to detect nucleocapsid (N) or spike protein. It puts focus on the manufacturer’s claims of a testing ability. The new COVID-19 dashboard brings attention to the targets of proteins and genes of SARS-COV-2.
Avigna Diagnostics presents the public data associated with a lab dashboard for new variants of coronavirus. This is purely an assumptive data filed as mutants are changing the performance levels at a quicker rate than expected.
The Global Dashboard for COVID-19 Diagnostic Tests
| Manufacturer | Head Quarters | Diagnostics | Approval of regulatory bodies |
| 3B Black BIO Biotech India | India | TRUE PCR SARS-COV-2 RT qPCR Kit | SRAS-1
LMICs-1 Type: Molecular |
| TRUE PCR SARS-COV-2 RT qPCR Kit – version 2 | |||
| Accuster Technologies Private Limited | India | Accuster SARS-COV2-RT-PCR test kit | SRAS-0
LMICs-0 Type: Molecular |
| COVID-19 Rapid IgG/IgM Test kit | |||
| Advy Chemical Private limited | EzDx COVID-19 IgG/IgM Rapid Antibody Test for detection of IgG and IgM antibodies | SRAS-0
LMICs-0 Type: Molecular |
|
| Affigenix Biosolutions | India | AG-Q-COVID-19 N Antigen Rapid Diagnostic Kit | SRAS-0
LMICs-1 Type: Molecular |
Regulatory approvals are currently inclusive of Emergency Use Authorizations and CE-IVD. SRA or Stringent Regulatory Approvals currently include US FDA, Canada (Health Canada) Japan (PMDA), and WHO EUL. The pipeline may not represent a comprehensive landscape of all diagnostic tests.
The Pandemic is not Going Away, as Yet!
Regular diagnosis and testing will continue to remain vital to monitor the new variants of coronavirus. Flu-like symptoms will continue to persist across the world. The original virus will not change its properties. But some of the variants will appear to affect the performance of the vaccines which will be introduced in the market. It will also impact the diagnostic tools, methods of investigations and analysis as data continues to emerge. Public measures to curtail will focus on new vaccines and the people being masked all the time outdoors. In 2021, global monitoring and research have given rise to lab dashboards to allow all stakeholders to respond to the pandemic.
Cutting Transmission by Controlled Measures
Detecting signals during testing that help labs to restrict the virus is critical to global health. We need to continue reducing the rate of transmission through the proven methods which are successful. Locally, administrations will have to work with the medical health authorities to monitor human and also animal populations. All countries need to work on social measures to keep people safe and healthy. As variants rise labs will continue to focus on any new epidemiological events that occur.
In India, the National Health Laboratory continues to maintain a dashboard of the COVID-19 variant. The dire situation that unfolded between April 2021 and June 2021 has alerted the medical authorities and the government. All viruses evolve over time and so will this new variant. When a virus is moving across a large population and gets an opportunity to spread it is likely to replicate itself. As it replicates, it causes new problems to the human body.
Avigna Diagnostics, recommends everyone to remain protected as all vaccines may not be able to make immunity stronger. As new data comes we will update the concerned citizens.
Related Keywords:
COVID-19 Dashboard, COVID-19 Variant, Variants of Coronavirus, Variants of COVID-19
Comments by admin